Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
BULLISH SIGNAL DETECTED
██.█% Sign up free to reveal

Prothena Corp Public Ltd Co (PRTA) AI Forecast

Our AI detected a significant signal for Prothena Corp Public Ltd Co. Create a free account to see the exact price target.

✓ Free account • ✓ 30-day free trial

$PRTA Bullish Signal Full forecast available
Sign Up Free

Prothena Corp Public Ltd Co (PRTA) Stock Forecast 2025

Prothena Corp Public Ltd Co (PRTA) AI Stock Price Forecast & Investment Analysis

Prothena Corp Public Ltd Co Stock Price Chart and Technical Analysis

Loading chart...

Prothena Corp Public Ltd Co (PRTA) - Comprehensive Stock Analysis & Investment Research

Deep dive into Prothena Corp Public Ltd Co's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on May 28, 2026, 5:45 p.m. (UTC)

Prothena Corp Public Ltd Co Investment Summary

When evaluating whether Prothena Corp Public Ltd Co (PRTA) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Prothena Corp Public Ltd Co (PRTA) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $532 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers Prothena Corp Public Ltd Co's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Prothena Corp Public Ltd Co along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Prothena Corp Public Ltd Co is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Prothena Corp Public Ltd Co

Sign Up Free
Corporate Identity

Prothena Corp Public Ltd Co (Stock Symbol: PRTA) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Prothena Corp Public Ltd Co's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Prothena Corp Public Ltd Co...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Prothena Corp Public Ltd Co...

Unlock Full Company Profile

Get complete details about Prothena Corp Public Ltd Co

Sign Up Free
Revenue & Growth Analysis

Prothena Corp Public Ltd Co generates annual revenues of $57 million , representing an emerging company in its growth phase.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Prothena Corp Public Ltd Co...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Prothena Corp Public Ltd Co...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Prothena Corp Public Ltd Co...

Unlock Financial Analysis

Get complete financial metrics for Prothena Corp Public Ltd Co

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Prothena Corp Public Ltd Co's AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Prothena Corp Public Ltd Co strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

Prothena Corp Public Ltd Co competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency
Asset Utilization Efficiency

Asset turnover ratio of 0.17x indicates lower asset turnover that may reflect the industry's capital-intensive nature or potentially underutilized assets. Companies with low turnover typically depend on strong margins to generate adequate returns on capital.

Financial Strength & Leverage

Current ratio of 10.43 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.

Prothena Corp Public Ltd Co (PRTA) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Prothena Corp Public Ltd Co stock analysis.

Deep dive into Prothena Corp Public Ltd Co's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Prothena Corp Public Ltd Co stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Prothena Corp Public Ltd Co:

P/B Ratio 1.70x
Market Cap $532M
Book Value/Share $5.89
Revenue/Share $1.09
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Prothena Corp Public Ltd Co converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Prothena Corp Public Ltd Co: An ROE of -11.5% indicates room for improvement in shareholder value creation.

ROE -11.5%
ROA -10.2%
ROIC -11.3%
Tax Rate -0.1%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Prothena Corp Public Ltd Co's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Prothena Corp Public Ltd Co: A current ratio of 10.43 indicates strong liquidity.

Current Ratio 10.43x
D/E Ratio 0.12x
Financial Leverage 1.12x
Interest Coverage 12.4x
Working Capital $307M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Prothena Corp Public Ltd Co's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Prothena Corp Public Ltd Co:

Operating Cash Flow -$20M
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Prothena Corp Public Ltd Co uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Prothena Corp Public Ltd Co: An asset turnover of 0.17x suggests room for improvement in asset utilization.

Asset Turnover 0.17x
Fixed Assets Turnover 29.6x
Understanding Financial Statement Data

What these metrics mean: Key figures from Prothena Corp Public Ltd Co's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Prothena Corp Public Ltd Co: With annual revenue of $57M, Prothena Corp Public Ltd Co represents a smaller but potentially high-growth operation.

Income Statement
Total Revenue $57M
Operating Income -$35M
Net Income -$35M
R&D Expense $24M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 339%
Cash & Short-term Investments 329%
Total Liabilities 37%
Short-term Debt 28%
Dividend & Shareholder Information
Shares Outstanding 53M

Latest Prothena Corp Public Ltd Co Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Prothena Corp Public Ltd Co (PRTA) stock price and investment outlook.

📰 We are currently updating our news feed for Prothena Corp Public Ltd Co. Check back soon for the latest market analysis and company updates.

Prothena Corp Public Ltd Co Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of Prothena Corp Public Ltd Co against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Aardvark Therapeutics, Inc. AARD ██% $86M x 1.0x
Abbvie Inc. ABBV ██% $381.28B 104.9x x
Abcellera Biologics Inc. ABCL ██% $1.65B x 1.8x
Abeona Therapeutics Inc. ABEO ██% $328M 5.0x 2.3x
Abbott Laboratories ABT ██% $149.24B 23.8x 2.9x
Arbutus Biopharma Corp ABUS ██% $914M 5.7x 3.5x
Abvc Biopharma, Inc. ABVC ██% $36M x 3.3x
Abivax S.A. ABVX ██% $10.19B x x
Acadia Pharmaceuticals Inc ACAD ██% $3.70B 9.9x 3.0x
Adicet Bio, Inc. ACET ██% $79M x 0.6x
Aclaris Therapeutics, Inc. ACRS ██% $640M x 4.5x
Acrivon Therapeutics, Inc. ACRV ██% $64M x 0.7x
Actuate Therapeutics, Inc. ACTU ██% $120M x 11.0x
Accustem Sciences Inc. ACUT ██% $4M x x
Acurx Pharmaceuticals, Inc. ACXP ██% $9M x 1.2x
Adagene Inc. ADAG ██% $274M x 7.2x
Adc Therapeutics Sa ADCT ██% $437M x x
Adial Pharmaceuticals, Inc. ADIL ██% $5M x 1.4x
Aditxt, Inc. ADTX ██% $170K x x
Addex Therapeutics Ltd. ADXN ██% $9M x x
Aeon Biopharma, Inc. AEON ██% $19M x x
Agios Pharmaceuticals, Inc. AGIO ██% $1.70B x 1.5x
Akebia Therapeutics, Inc. AKBA ██% $276M x 10.1x
Akero Therapeutics, Inc. AKRO ██% $4.38B -8.7x 4.6x
Akari Therapeutics Plc AKTX ██% $18M x 1.3x
Aldeyra Therapeutics, Inc. ALDX ██% $103M x 2.5x
Alkermes Plc. ALKS ██% $6.34B 41.5x 3.6x
Allarity Therapeutics, Inc. ALLR ██% $27M x 4.0x
Alumis Inc. ALMS ██% $2.67B x 4.7x
Alnylam Pharmaceuticals, Inc. ALNY ██% $39.13B 124.7x 49.6x
Altimmune, Inc. ALT ██% $580M x 2.0x
Alx Oncology Holdings Inc ALXO ██% $263M x 1.7x
Alzamend Neuro, Inc. ALZN ██% $4M x 2.0x
Amylyx Pharmaceuticals, Inc. AMLX ██% $1.56B x 5.7x
Amphastar Pharmaceuticals, Inc. AMPH ██% $853M 10.8x 1.1x
Amarin Corp Plc\Uk AMRN ██% $304M x 0.7x
Amneal Pharmaceuticals, Inc. AMRX ██% $4.06B 33.3x x
Anaptysbio, Inc ANAB ██% $1.67B x 131.4x
Anebulo Pharmaceuticals, Inc. ANEB ██% $19M x 2.4x
Ani Pharmaceuticals Inc ANIP ██% $1.71B 18.6x 3.0x
Anixa Biosciences Inc ANIX ██% $89M x 5.9x
Annexon, Inc. ANNX ██% $836M x 4.1x
Alto Neuroscience, Inc. ANRO ██% $716M x 2.9x
An2 Therapeutics, Inc. ANTX ██% $165M x 2.0x
Annovis Bio, Inc. ANVS ██% $86M x 27.4x
Apollomics Inc. APLM ██% $31M x x
Apellis Pharmaceuticals, Inc. APLS ██% $5.25B 39.4x 12.7x
Applied Therapeutics, Inc. APLT ██% $15M -0.7x 0.9x
Aprea Therapeutics, Inc. APRE ██% $11M x 0.3x
Apimeds Pharmaceuticals Us, Inc. APUS ██% $18M x 0.1x
Aptevo Therapeutics Inc. APVO ██% $6M x 0.5x
Aquestive Therapeutics, Inc. AQST ██% $497M x x
Arcturus Therapeutics Holdings Inc. ARCT ██% $218M x 1.1x
Ardelyx, Inc. ARDX ██% $1.52B x 10.3x
Arcutis Biotherapeutics, Inc. ARQT ██% $2.71B x 14.3x
Artelo Biosciences, Inc. ARTL ██% $4M x 0.5x
Arvinas, Inc. ARVN ██% $571M x 1.5x
Arrowhead Pharmaceuticals, Inc. ARWR ██% $11.10B x 18.1x
Aspire Biopharma Holdings, Inc. ASBP ██% $6M x 1.6x
Assembly Biosciences, Inc. ASMB ██% $527M x 2.7x
Ascendis Pharma A/S ASND ██% $14.58B x x
Assertio Holdings, Inc. ASRT ██% $151M x 2.0x
Atai Beckley N.V. ATAI ██% $1.61B x 10.1x
Alterity Therapeutics Ltd ATHE ██% $77M x x
Actinium Pharmaceuticals, Inc. ATNM ██% $37M x 16.1x
Atossa Therapeutics, Inc. ATOS ██% $44M x 1.5x
Avenue Therapeutics, Inc. ATXI ██% $1M x 1.0x
Astria Therapeutics, Inc. ATXS ██% $710M -4.7x 3.0x
Aurinia Pharmaceuticals Inc. AUPH ██% $2.01B 6.7x 3.5x
Arrivent Biopharma, Inc. AVBP ██% $1.24B x 3.8x
Avadel Pharmaceuticals Plc AVDL ██% $2.10B -10.2x 21.4x
Atea Pharmaceuticals, Inc. AVIR ██% $364M x 1.6x
Avalo Therapeutics, Inc. AVTX ██% $843M x 12.3x
Axim Biotechnologies, Inc. AXIM ██% $2M x x
Axsome Therapeutics, Inc. AXSM ██% $12.06B x 220.9x
Aytu Biopharma, Inc AYTU ██% $27M -0.3x 1.2x
Azitra, Inc. AZTR ██% $3M x 0.3x
Bridgebio Pharma, Inc. BBIO ██% $13.18B x x
Bridgebio Oncology Therapeutics, Inc. BBOT ██% $683M x 1.8x
Bicara Therapeutics Inc. BCAX ██% $1.41B x 2.8x
Briacell Therapeutics Corp. BCTX ██% $26M x 0.9x
Bicycle Therapeutics Plc BCYC ██% $319M x 0.6x
Bioadaptives, Inc. BDPT ██% $130K x x
Biodexa Pharmaceuticals Plc BDRX ██% $510K x x
Beone Medicines Ltd. BEIGF ██% $36.38B 530.6x 8.8x
Bullfrog Ai Holdings, Inc. BFRG ██% $12M x 2.6x
Biofrontera Inc. BFRI ██% $10M x 1.7x
Bio Green Med Solution, Inc. BGMS ██% $5M x 0.8x
Bausch Health Companies Inc. BHC ██% $2.01B x x
Bioharvest Sciences Inc. BHST ██% $89M x 3.5x
Biohaven Ltd. BHVN ██% $1.22B -4.6x 23.4x
Bioage Labs, Inc. BIOA ██% $752M x 2.0x
Bio Essence Corp BIOE ██% $13M 9.8x x
Biovie Inc. BIVI ██% $11M x 0.7x
Bioxytran, Inc BIXT ██% $3M x x
Biolinerx Ltd. BLRX ██% $15M x x
Belite Bio, Inc BLTE ██% $5.59B x 7.3x
Biomea Fusion, Inc. BMEA ██% $98M x 5.3x
Biomarin Pharmaceutical Inc BMRN ██% $10.16B 37.8x 1.6x
Bristol Myers Squibb Co BMY ██% $115.25B 15.8x 5.7x
Bristol Myers Squibb Co BMYMP ██% $1.73T 287.0x 93.4x
Benitec Biopharma Inc. BNTC ██% $399M x 2.2x
Boundless Bio, Inc. BOLD ██% $33M x 0.4x
Bolt Biotherapeutics, Inc. BOLT ██% $10M x 0.5x
Bio-Path Holdings, Inc. BPTH ██% $2M x x
Bioquest Corp BQST ██% $2M x x
Barinthus Biotherapeutics Plc. BRNS ██% $29M x 0.4x
Bespoke Extracts, Inc. BSPK ██% $2M x x
Bioxcel Therapeutics, Inc. BTAI ██% $40M x x
Beyondspring Inc. BYSI ██% $70M x x
Calcimedica, Inc. CALC ██% $12M x x
Camp4 Therapeutics Corp CAMP ██% $208M -0.1x 4.4x
Can-Fite Biopharma Ltd. CANF ██% $7M x 1.3x
Capricor Therapeutics, Inc. CAPR ██% $1.68B x 6.0x
Carisma Therapeutics Inc. CARM ██% $0.00M 0.0x x
Casi Pharmaceuticals, Inc. CASI ██% $5M -1.4x 2.5x
Perspective Therapeutics, Inc. CATX ██% $474M x 1.4x
Gyre Therapeutics, Inc. CBIO ██% $606M x 6.0x
Cdt Equity Inc. CDT ██% $5M x 1.3x
Cingulate Inc. CING ██% $58M x 3.1x
Cell Source, Inc. CLCS ██% $54M x x
Clene Inc. CLNN ██% $79M x x
Cellectar Biosciences, Inc. CLRB ██% $25M x 7.5x
Clearside Biomedical, Inc. CLSD ██% $4M -2.0x -0.7x
Clearside Biomedical, Inc. CLSDQ ██% $2M x x
Climb Bio, Inc. CLYM ██% $685M x 4.6x
Chemomab Therapeutics Ltd. CMMB ██% $14M x 1.1x
Clearmind Medicine Inc. CMND ██% $3M x x
Compass Pathways Plc CMPS ██% $1.60B x 4.9x
Cnbx Pharmaceuticals Inc. CNBX ██% $110K x x
Cns Pharmaceuticals, Inc. CNSP ██% $7M x 105.8x
Centessa Pharmaceuticals Plc CNTA ██% $6.15B x 12.6x
Connect Biopharma Holdings Ltd CNTB ██% $136M x 3.2x
Canton Strategic Holdings, Inc. CNTN ██% $223M x 0.5x
Context Therapeutics Inc. CNTX ██% $269M x 5.2x
Cocrystal Pharma, Inc. COCP ██% $15M x 3.8x
Cogent Biosciences, Inc. COGT ██% $5.89B x 9.7x
Collegium Pharmaceutical, Inc COLL ██% $1.09B 14.6x 3.5x
Corcept Therapeutics Inc CORT ██% $6.96B 147.0x 10.9x
Coya Therapeutics, Inc. COYA ██% $110M x 2.3x
China Pharma Holdings, Inc. CPHI ██% $30M x 0.8x
Cumberland Pharmaceuticals Inc CPIX ██% $88M x 4.1x
Cannapharmarx, Inc. CPMD ██% $3M x x
Catalyst Pharmaceuticals, Inc. CPRX ██% $3.83B 17.3x 3.8x
Corbus Pharmaceuticals Holdings, Inc. CRBP ██% $139M x 1.1x
Cormedix Inc. CRMD ██% $663M 3.7x 1.5x
Crinetics Pharmaceuticals, Inc. CRNX ██% $3.87B x 3.0x
Cervomed Inc. CRVO ██% $28M x 2.7x
Corvus Pharmaceuticals, Inc. CRVS ██% $1.09B x 4.5x
Cytomx Therapeutics, Inc. CTMX ██% $829M x 2.6x
Contineum Therapeutics, Inc. CTNM ██% $502M x 2.0x
Citius Oncology, Inc. CTOR ██% $83M x 2.3x
Hepion Pharmaceuticals, Inc. CTRVP ██% $20K x 0.0x
Ctt Pharmaceutical Holdings, Inc. CTTH ██% $4M x 5.8x
Citius Pharmaceuticals, Inc. CTXR ██% $19M x 0.3x
Cue Biopharma, Inc. CUE ██% $83M x 3.8x
Curanex Pharmaceuticals Inc CURX ██% $10M x 1.2x
Cadrenal Therapeutics, Inc. CVKD ██% $15M x 8.4x
Cv Sciences, Inc. CVSI ██% $6M x 3.9x
Cyclerion Therapeutics, Inc. CYCN ██% $13M x 2.0x
Cytodyn Inc. CYDY ██% $413M x x
Cypherpunk Technologies Inc. CYPH ██% $114M x 1.4x
Cryoport, Inc. CYRX ██% $704M 8.8x 1.4x
Cytokinetics Inc CYTK ██% $10.47B x x
Dare Bioscience, Inc. DARE ██% $34M x 46.2x
Day One Biopharmaceuticals, Inc. DAWN ██% $2.22B x 5.0x
Decoy Therapeutics Inc. DCOY ██% $4M x 1.1x
Journey Medical Corp DERM ██% $164M x 5.3x
Diamedica Therapeutics Inc. DMAC ██% $329M x 7.0x
Damora Therapeutics, Inc. DMRA ██% $1.55B x 3.0x
Dianthus Therapeutics, Inc. /De/ DNTH ██% $4.73B x 3.9x
Dermata Therapeutics, Inc. DRMA ██% $5M x 0.8x
Bright Minds Biosciences Inc. DRUG ██% $854M x x
Design Therapeutics, Inc. DSGN ██% $693M x 3.2x
Dynavax Technologies Corp DVAX ██% $1.82B 88.2x 3.4x
Dogwood Therapeutics, Inc. DWTX ██% $57M x 0.7x
Dyne Therapeutics, Inc. DYN ██% $3.00B x 3.5x
Emergent Biosolutions Inc. EBS ██% $466M x 0.9x
Edesa Biotech, Inc. EDSA ██% $71M x 7.0x
Eagle Pharmaceuticals, Inc. EGRX ██% $4M 0.4x 0.0x
Pmgc Holdings Inc. ELAB ██% $8M x 0.6x
Elanco Animal Health Inc ELAN ██% $11.83B x 1.8x
Eledon Pharmaceuticals, Inc. ELDN ██% $296M x 6.6x
Elite Pharmaceuticals Inc /Nv/ ELTP ██% $365M 13.4x 4.6x
Elicio Therapeutics, Inc. ELTX ██% $201M x x
Enliven Therapeutics, Inc. ELVN ██% $2.52B x 5.6x
Emmaus Life Sciences, Inc. EMMA ██% $700K x x
Enlivex Ltd. ENLV ██% $188M 0.1x 0.1x
Ensysce Biosciences, Inc. ENSC ██% $4M x x
Enanta Pharmaceuticals Inc ENTA ██% $385M x 3.3x
Gridai Technologies Corp. ENTO ██% $7M 0.0x 0.3x
Enveric Biosciences, Inc. ENVB ██% $8M x 1.6x
Evolus, Inc. EOLS ██% $407M x x
Essa Pharma Inc. EPIX ██% $9M -2.7x 0.1x
Eupraxia Pharmaceuticals Inc. EPRX ██% $469M x 5.7x
Equillium, Inc. EQ ██% $166M x 2.8x
Erasca, Inc. ERAS ██% $3.88B x 9.9x
Ernexa Therapeutics Inc. ERNA ██% $13M x 1.9x
Esperion Therapeutics, Inc. ESPR ██% $787M x x
89bio, Inc. ETNB ██% $2.20B -3.5x 4.2x
Eton Pharmaceuticals, Inc. ETON ██% $886M x 29.0x
Earth Science Tech, Inc. ETST ██% $48M 11.9x 8.4x
Evofem Biosciences, Inc. EVFM ██% $930K x x
Evommune, Inc. EVMN ██% $841M x 2.8x
Edgewise Therapeutics, Inc. EWTX ██% $3.60B x 7.3x
Fuss Brands Corp. FBDS ██% $2M x 0.0x
Fortress Biotech, Inc. FBIO ██% $92M 0.7x 0.6x
Fortress Biotech, Inc. FBIOP ██% $394M 98.8x 7.1x
Fibrobiologics, Inc. FBLG ██% $6M x 2.2x
Forte Biosciences, Inc. FBRX ██% $440M x 10.4x
Fibrogen Inc FGEN ██% $35M 0.2x -3.6x
Foghorn Therapeutics Inc. FHTX ██% $251M x x
Filana Therapeutics, Inc. FLNA ██% $72M x 1.1x
Amicus Therapeutics, Inc. FOLD ██% $4.50B x 16.4x
Fulcrum Therapeutics, Inc. FULC ██% $450M x 1.4x
Galectin Therapeutics Inc GALT ██% $178M x x
Gain Therapeutics, Inc. GANX ██% $75M x 5.4x
Generation Bio Co. GBIO ██% $36M -0.6x 0.7x
Greater Cannabis Company, Inc. GCAN ██% $140K x x
Cytomed Therapeutics Ltd GDTC ██% $14M x x
Geron Corp GERN ██% $822M x 3.6x
Gh Research Plc GHRS ██% $1.39B x x
Galmed Pharmaceuticals Ltd. GLMD ██% $4M x 0.3x
Lakefront Biotherapeutics Nv GLPG ██% $1.85B x x
Greenwich Lifesciences, Inc. GLSI ██% $403M x 184.5x
Galecto, Inc. GLTO ██% $1.59B -2.5x 198.2x
Genelux Corp GNLX ██% $137M x 6.0x
Genprex, Inc. GNPX ██% $8M x 0.5x
Gossamer Bio, Inc. GOSS ██% $51M x x
Geovax Labs, Inc. GOVX ██% $14M x 28.2x
Structure Therapeutics Inc. GPCR ██% $2.81B x 1.9x
Grace Therapeutics, Inc. GRCE ██% $36M x 0.6x
Gridai Technologies Corp. GRDX ██% $30M x 1.6x
Gri Bio, Inc. GRI ██% $4M x 0.4x
Galera Therapeutics, Inc. GRTX ██% $21M 0.1x 29.3x
Gsk Plc GSK ██% $103.46B x x
Gt Biopharma, Inc. GTBP ██% $14M x 1.9x
Gyre Therapeutics, Inc. GYRE ██% $541M x 5.3x
Hutchmed (China) Ltd HCM ██% $2.02B 2.2x 1.6x
Hcw Biologics Inc. HCWB ██% $14M x 2.4x
Cybin Inc. HELP ██% $221M x x
Hepion Pharmaceuticals, Inc. HEPA ██% $2M x 1.0x
Vyome Holdings, Inc HIND ██% $16M x 2.3x
Hutchmed (China) Ltd HMDCF ██% $2.64B x 2.1x
Hookipa Pharma Inc. HOOK ██% $15M x 0.4x
Rocket One Inc. HOTH ██% $26M x 6.3x
Werewolf Therapeutics, Inc. HOWL ██% $24M x 2.0x
Harmony Biosciences Holdings, Inc. HRMY ██% $1.78B 12.2x 2.0x
Heron Therapeutics, Inc. /De/ HRTX ██% $173M x 18.9x
Hst Global, Inc. HSTC ██% $99M x 79.9x
Tuhura Biosciences, Inc./Nv HURA ██% $151M x 6.5x
Mindwalk Holdings Corp. HYFT ██% $80M x x
Hyperion Defi, Inc. HYPD ██% $55M x 0.9x
Ibio, Inc. IBIO ██% $93M x 1.2x
Impact Biomedical Inc. IBO ██% $53M x 4.6x
Ideaya Biosciences, Inc. IDYA ██% $2.57B x 2.8x
Inflarx N.V. IFRX ██% $377M x x
Igc Pharma, Inc. IGC ██% $29M x 4.7x
Immutep Ltd IMMP ██% $63M x x
Immix Biopharma, Inc. IMMX ██% $621M x 7.4x
Immunome Inc. IMNM ██% $2.50B x 4.3x
Imunon, Inc. IMNN ██% $9M x 2.7x
Immuron Ltd IMRN ██% $10M x x
Immuneering Corp IMRX ██% $345M x 1.7x
Eom Pharmaceutical Holdings, Inc. IMUC ██% $6M x 1.8x
Immunic, Inc. IMUX ██% $191M x 1.3x
Integrated Biopharma Inc INBP ██% $6M x 0.3x
Indaptus Therapeutics, Inc. INDP ██% $144M x 115.3x
Indivior Pharmaceuticals, Inc. INDV ██% $4.60B 18.3x x
Inmed Pharmaceuticals Inc. INM ██% $6M x 0.8x
Inovio Pharmaceuticals, Inc. INO ██% $103M x 17.0x
Insmed Inc INSM ██% $23.04B x 32.7x
Inhibitor Therapeutics, Inc. INTI ██% $15M x x
Innoviva, Inc. INVA ██% $1.63B 3.2x 1.2x
Io Biotech, Inc. IOBT ██% $540K x 0.6x
Io Biotech, Inc. IOBTQ ██% $140K x 0.2x
Ionis Pharmaceuticals Inc IONS ██% $12.69B x 25.8x
Opus Genetics, Inc. IRD ██% $337M x x
Disc Medicine, Inc. IRON ██% $2.66B x 3.9x
Ironwood Pharmaceuticals Inc IRWD ██% $611M 6.0x x
International Stem Cell Corp ISCO ██% $1M x x
Iterum Therapeutics Plc ITRM ██% $1M x x
Inventiva S.A. IVA ██% $1.09B x x
Incannex Healthcare Inc. IXHL ██% $39M x 0.5x
Jaguar Health, Inc. JAGX ██% $2M x x
Janux Therapeutics, Inc. JANX ██% $879M x 0.9x
Jazz Pharmaceuticals Plc JAZZ ██% $14.70B 498.6x 3.2x
Jade Biosciences, Inc. JBIO ██% $1.06B x 3.6x
Johnson & Johnson JNJ ██% $557.11B 26.5x 6.9x
Jupiter Neurosciences, Inc. JUNS ██% $10M x x
Kala Bio, Inc. KALA ██% $43M x 4.0x
Kalvista Pharmaceuticals, Inc. KALV ██% $1.37B x x
Kairos Pharma, Ltd. KAPA ██% $11M x 2.1x
Kaya Holdings, Inc. KAYS ██% $23M x x
Kamada Ltd KMDA ██% $460M x x
Kiniksa Pharmaceuticals International, Plc KNSA ██% $3.97B 54.3x 6.6x
Kiora Pharmaceuticals Inc KPRX ██% $7M -2.4x 0.3x
Karyopharm Therapeutics Inc. KPTI ██% $202M x x
Keros Therapeutics, Inc. KROS ██% $223M x 0.8x
Korro Bio, Inc. KRRO ██% $198M x 1.7x
Pasithea Therapeutics Corp. KTTA ██% $23M x 0.4x
Kura Oncology, Inc. KURA ██% $909M x 8.4x
Kyntra Bio, Inc. KYNB ██% $28M 0.2x x
Kezar Life Sciences, Inc. KZR ██% $54M x 0.8x
Lb Pharmaceuticals Inc LBRX ██% $797M x 2.1x
Legend Biotech Corp LEGN ██% $5.29B x x
Lexaria Bioscience Corp. LEXX ██% $15M x 2.3x
Lifecore Biomedical, Inc. \De\ LFCR ██% $181M x x
Lifevantage Corp LFVN ██% $102M 12.8x 3.0x
Ligand Pharmaceuticals Inc LGND ██% $4.72B 30.8x 4.7x
Longeveron Inc. LGVN ██% $25M x 1.6x
Lianbio LIANY ██% $12M x 0.1x
Lftd Partners Inc. LIFD ██% $3M x 0.3x
Lipella Pharmaceuticals Inc. LIPO ██% $460K x 0.3x
Lite Strategy, Inc. LITS ██% $35M x 0.6x
Lixte Biotechnology Holdings, Inc. LIXT ██% $80M x 10.0x
Lixte Biotechnology Holdings, Inc. LIXTW ██% $130K x 0.0x
Lakefront Biotherapeutics Nv LKFT ██% $1.83B x x
Eli Lilly & Co LLY ██% $968.67B 38.3x 31.1x
Lunai Bioworks Inc. LNAI ██% $12M x x
Lipocine Inc. LPCN ██% $17M x 0.8x
Cypherpunk Technologies Inc. LPTX ██% $94M -1.1x 35.1x
Liquidia Corp LQDA ██% $5.48B 245.6x 50.5x
Larimar Therapeutics, Inc. LRMR ██% $366M x 2.3x
Lisata Therapeutics, Inc. LSTA ██% $30M x 2.8x
Lantern Pharma Inc. LTRN ██% $42M x 12.3x
Lava Therapeutics Nv LVTX ██% $46M x 3.6x
Lexicon Pharmaceuticals, Inc. LXRX ██% $924M x 4.6x
Lyell Immunopharma, Inc. LYEL ██% $390M x 1.4x
Maia Biotechnology, Inc. MAIA ██% $80M x 2.9x
Mustang Bio, Inc. MBIO ██% $5M x 0.6x
Moleculin Biotech, Inc. MBRX ██% $15M x 1.0x
Mbx Biosciences, Inc. MBX ██% $1.52B x 3.5x
Seres Therapeutics, Inc. MCRB ██% $73M x 2.8x
Medicus Pharma Ltd. MDCX ██% $18M x 13.2x
Medicus Pharma Ltd. MDCXW ██% $52M x x
Madrigal Pharmaceuticals, Inc. MDGL ██% $12.16B x 22.4x
Chrome Holding Co. MEHCQ ██% $96M x x
Macrogenics Inc MGNX ██% $278M x 13.1x
Mira Pharmaceuticals, Inc. MIRA ██% $49M x 5.2x
Mirum Pharmaceuticals, Inc. MIRM ██% $5.93B x 24.5x
Milestone Pharmaceuticals Inc. MIST ██% $165M x 4.6x
Moonlake Immunotherapeutics MLTX ██% $1.31B x 5.2x
Mineralys Therapeutics, Inc. MLYS ██% $2.47B x 3.9x
Mannkind Corp MNKD ██% $1.10B x x
Medicinova Inc MNOV ██% $65M x 1.7x
Monopar Therapeutics MNPR ██% $432M x 3.2x
Maplight Therapeutics, Inc. MPLT ██% $1.34B x 3.3x
Mereo Biopharma Group Plc MREO ██% $53M x 1.5x
Merck & Co., Inc. MRK ██% $297.23B 33.3x 6.5x
Marker Therapeutics, Inc. MRKR ██% $24M x 1.8x
Mersana Therapeutics, Inc. MRSN ██% $145M -3.4x -1.4x
Merus N.V. MRUS ██% $6.83B -13.5x 8.8x
Maravai Lifesciences Holdings, Inc. MRVI ██% $1.61B x 7.6x
Matinas Biopharma Holdings, Inc. MTNB ██% $5M x 1.6x
Metsera, Inc. MTSR ██% $7.41B x 22.0x
Metavia Inc. MTVA ██% $17M x 1.9x
Mural Oncology Plc MURA ██% $35M x 0.6x
Mainz Biomed N.V. MYNZ ██% $7M x x
Newamsterdam Pharma Co N.V. NAMS ██% $4.26B x 6.4x
Newamsterdam Pharma Co N.V. NAMSW ██% $2.59B x 3.6x
Natures Sunshine Products Inc NATR ██% $384M 19.3x 2.3x
Novabridge Biosciences NBP ██% $216M x 0.8x
Nanobiotix S.A. NBTX ██% $1.49B x x
Stablecoin Development Corp NBY ██% $37M x x
Newcelx Ltd. NCEL ██% $19M x 34.3x
Nucana Plc NCNA ██% $9M x x
Minerva Neurosciences, Inc. NERV ██% $231M x x
Neuphoria Therapeutics Inc. NEUP ██% $29M x 1.0x
Neurogene Inc. NGNE ██% $420M x 1.8x
Nika Pharmaceuticals, Inc NIKA ██% $212M x x
Nektar Therapeutics NKTR ██% $2.21B x 3.8x
Nkarta, Inc. NKTX ██% $237M x 0.8x
Newcelx Ltd. NLSP ██% $54M x 98.9x
Newcelx Ltd. NLSPW ██% $120K x 0.2x
Nanoviricides, Inc. NNVC ██% $38M x 4.1x
Nurix Therapeutics, Inc. NRIX ██% $1.81B x 3.8x
Neurosense Therapeutics Ltd. NRSN ██% $32M x x
Nrx Pharmaceuticals, Inc. NRXP ██% $143M x x
Neonc Technologies Holdings, Inc. NTHI ██% $120M x x
Nuvation Bio Inc. NUVB ██% $1.64B x 5.1x
Nuvalent, Inc. NUVL ██% $8.45B x 7.2x
Nuvectis Pharma, Inc. NVCT ██% $269M x 18.9x
Novartis Ag NVS ██% $288.36B x x
Northwest Biotherapeutics Inc NWBO ██% $337M x x
Nexien Biopharma, Inc. NXEN ██% $10K x x
Nextcure, Inc. NXTC ██% $22M x 0.8x
Nexentis Technologies Inc. NXTS ██% $4M x 0.3x
Ocean Biomedical, Inc. OCEA ██% $190K -0.3x 0.1x
Ocular Therapeutix, Inc OCUL ██% $1.87B x 3.2x
Oragenics Inc OGEN ██% $3M x 0.4x
Organigram Global Inc. OGI ██% $156M x x
Organon & Co. OGN ██% $3.51B 14.3x 3.9x
Onkure Therapeutics, Inc. OKUR ██% $166M x 0.9x
Olema Pharmaceuticals, Inc. OLMA ██% $1.13B x 2.4x
Omeros Corp OMER ██% $797M 9.3x x
Beone Medicines Ltd. ONC ██% $31.13B 60.7x 6.5x
Onconetix, Inc. ONCO ██% $1M x 0.1x
Oncolytics Biotech Inc ONCY ██% $105M x x
Opko Health, Inc. OPK ██% $987M x 0.8x
Organogenesis Holdings Inc. ORGO ██% $342M 125.9x 1.4x
Orgenesis Inc. ORGS ██% $3M x x
Oric Pharmaceuticals, Inc. ORIC ██% $888M x 2.1x
Oruka Therapeutics, Inc. ORKA ██% $3.50B x 7.2x
Oramed Pharmaceuticals Inc. ORMP ██% $163M 1.5x 0.7x
Os Therapies Inc OSTX ██% $84M x x
Oncotelic Therapeutics, Inc. OTLC ██% $27M x 0.1x
Ovid Therapeutics Inc. OVID ██% $474M x 2.4x
One World Products, Inc. OWPC ██% $770K x x
Phibro Animal Health Corp PAHC ██% $1.33B 14.0x 3.7x
Prestige Consumer Healthcare Inc. PBH ██% $2.34B 12.3x 1.2x
Psyence Biomedical Ltd. PBM ██% $10M x x
Puma Biotechnology, Inc. PBYI ██% $372M 15.3x 2.9x
Pacira Biosciences, Inc. PCRX ██% $945M 183.9x 1.5x
Processa Pharmaceuticals, Inc. PCSA ██% $6M x 2.5x
Procyon Corp PCYN ██% $2M x 0.7x
Pds Biotechnology Corp PDSB ██% $62M x 15.9x
Pepgen Inc. PEPG ██% $105M x 0.8x
Pfizer Inc PFE ██% $149.16B 19.9x 1.7x
Precigen, Inc. PGEN ██% $1.57B x 77.4x
Phathom Pharmaceuticals, Inc. PHAT ██% $853M x x
Phio Pharmaceuticals Corp. PHIO ██% $13M x 0.8x
Pharvaris N.V. PHVS ██% $2.06B x x
Protokinetix, Inc. PKTX ██% $2M x 9.0x
Plandai Biotechnology, Inc. PLPL ██% $4M x 14.6x
Pliant Therapeutics, Inc. PLRX ██% $77M x 0.5x
Polomar Health Services, Inc. PMHS ██% $4M x 0.5x
Promis Neurosciences Inc. PMN ██% $94M x 1.6x
Pmv Pharmaceuticals, Inc. PMVP ██% $64M x 0.7x
Purple Biotech Ltd. PPBT ██% $3M x x
Propanc Biopharma, Inc. PPCB ██% $4M x 0.4x
Praxis Precision Medicines, Inc. PRAX ██% $9.95B x 7.1x
Prf Technologies Ltd. PRFX ██% $1M x 0.1x
Perrigo Co Plc PRGO ██% $1.54B x 0.6x
Prelude Therapeutics Inc PRLD ██% $343M x 5.7x
Prophase Labs, Inc. PRPH ██% $470K x 0.1x
Proqr Therapeutics N.V. PRQR ██% $164M x x
Prothena Corp Public Ltd Co PRTA ██% $532M x 1.7x
Ptc Therapeutics, Inc. PTCT ██% $5.86B x x
Protagonist Therapeutics, Inc PTGX ██% $6.56B x 10.0x
Protagenic Therapeutics, Inc.\New PTIX ██% $1M x x
Palatin Technologies Inc PTN ██% $26M x 2.5x
Palatin Technologies Inc PTNT ██% $17M x 43.1x
Petros Pharmaceuticals, Inc. PTPI ██% $250K 0.1x 0.1x
Pulmatrix, Inc. PULM ██% $5M x 1.4x
Provectus Biopharmaceuticals, Inc. PVCT ██% $26M x x
Palvella Therapeutics, Inc. PVLA ██% $1.66B x 7.2x
Pyxis Oncology, Inc. PYXS ██% $109M x 3.5x
Aixcrypto Holdings, Inc. QLGN ██% $8M -1.3x 0.2x
Quoin Pharmaceuticals, Ltd. QNRX ██% $10M x 1.2x
Quantum Biopharma Ltd. QNTM ██% $49M x x
Q32 Bio Inc. QTTB ██% $218M 6.6x 4.7x
Quantum Cyber N.V. QUCY ██% $43M x 9.4x
Uniqure N.V. QURE ██% $1.59B x 10.6x
Radiopharm Theranostics Ltd RADX ██% $36M x x
Rani Therapeutics Holdings, Inc. RANI ██% $131M x 4.6x
Rapport Therapeutics, Inc. RAPP ██% $1.89B x 4.0x
Rapt Therapeutics, Inc. RAPT ██% $1.56B -0.4x 10.3x
Ultragenyx Pharmaceutical Inc. RARE ██% $2.30B x x
Rocket Pharmaceuticals, Inc. RCKT ██% $326M x 1.4x
Arcus Biosciences, Inc. RCUS ██% $3.01B x 5.7x
Dr Reddys Laboratories Ltd RDY ██% $11.34B x x
Regeneron Pharmaceuticals, Inc. REGN ██% $65.28B 14.8x 2.1x
Revelation Biosciences, Inc. REVB ██% $4M x 0.3x
Rafael Holdings, Inc. RFL ██% $70M x 0.9x
Regen Biopharma Inc RGBP ██% $180K x x
Regen Biopharma Inc RGBPP ██% $470K x x
Rigel Pharmaceuticals Inc RIGL ██% $543M 1.5x 1.4x
Relmada Therapeutics, Inc. RLMD ██% $762M x 3.5x
Rallybio Corp RLYB ██% $77M x 1.5x
Retrieve Medical Holdings, Inc. RMHI ██% $23M x x
Rockwell Medical, Inc. RMTI ██% $30M x 0.8x
Avidity Biosciences, Inc. RNA ██% $206M -12.2x 0.1x
Cartesian Therapeutics, Inc. RNAC ██% $198M x x
Transcode Therapeutics, Inc. RNAZ ██% $5M x 3.7x
Rein Therapeutics, Inc. RNTX ██% $91M x 7.8x
Renovorx, Inc. RNXT ██% $42M x 3.7x
Roivant Sciences Ltd. ROIV ██% $21.31B x 4.7x
Royalty Pharma Plc RPRX ██% $31.08B 37.6x 4.5x
Repare Therapeutics Inc. RPTX ██% $114M -2.1x 1.0x
Rest Ez Inc. RTEZ ██% $1.93B x x
Rapid Therapeutic Science Laboratories, Inc. RTSL ██% $110K 1.9x 0.3x
Reviva Pharmaceuticals Holdings, Inc. RVPH ██% $5M x 0.3x
Rhythm Pharmaceuticals, Inc. RYTM ██% $6.26B x 50.9x
Rezolute, Inc. RZLT ██% $320M x 2.7x
Filana Therapeutics, Inc. SAVA ██% $101M -1.9x 1.2x
Sunshine Biopharma Inc. SBFM ██% $7M x 0.3x
Scienture Holdings, Inc. SCNX ██% $16M x 0.2x
Scpharmaceuticals Inc. SCPH ██% $302M -2.0x -50.9x
Scorpius Holdings, Inc. SCPX ██% $610K x x
Scynexis Inc SCYX ██% $56M x 1.4x
Stablecoin Development Corp SDEV ██% $37M 0.1x 0.3x
Schrodinger, Inc. SDGR ██% $980M x 3.1x
Septerna, Inc. SEPN ██% $1.34B x 3.5x
Serina Therapeutics, Inc. SER ██% $27M x 1.5x
Sagimet Biosciences Inc. SGMT ██% $446M x 4.4x
Shuttle Pharmaceuticals Holdings, Inc. SHPH ██% $3M x 0.9x
Siga Technologies Inc SIGA ██% $339M 16.8x 2.2x
Silo Pharma, Inc. SILO ██% $7M x 1.2x
Sionna Therapeutics, Inc. SION ██% $1.96B x 6.8x
Skinvisible, Inc. SKVI ██% $1M x x
Skye Bioscience, Inc. SKYE ██% $29M x 3.2x
Sol-Gel Technologies Ltd. SLGL ██% $240M x 10.5x
Silence Therapeutics Plc SLN ██% $321M x 6.5x
Silence Therapeutics Plc SLNCF ██% $213M x 2.9x
Soleno Therapeutics Inc SLNO ██% $2.74B 28.6x 5.5x
Salarius Pharmaceuticals, Inc. SLRX ██% $2M -0.5x 0.4x
Sellas Life Sciences Group, Inc. SLS ██% $1.56B x 14.5x
Summit Therapeutics Inc. SMMT ██% $13.47B x 24.7x
Semnur Pharmaceuticals, Inc. SMNR ██% $691M x x
Syndax Pharmaceuticals Inc SNDX ██% $1.72B x 41.4x
Soligenix, Inc. SNGX ██% $13M x 4.2x
Sibannac, Inc. SNNC ██% $2M x x
Sensei Biotherapeutics, Inc. SNSE ██% $22M x x
Sanofi SNY ██% $105.47B x x
Sonnet Biotherapeutics Holdings, Inc. SONN ██% $4M -1.6x 29.5x
Spruce Biosciences, Inc. SPRB ██% $136M x 3.9x
Scisparc Ltd. SPRC ██% $7M x x
Spero Therapeutics, Inc. SPRO ██% $170M 11.1x 3.2x
Ars Pharmaceuticals, Inc. SPRY ██% $844M x 13.8x
Sarepta Therapeutics, Inc. SRPT ██% $1.76B 27.1x 1.2x
Stoke Therapeutics, Inc. STOK ██% $1.96B x 5.0x
Shattuck Labs, Inc. STTK ██% $458M x 4.8x
Supernus Pharmaceuticals, Inc. SUPN ██% $2.70B x 2.5x
Savara Inc SVRA ██% $1.07B x 6.1x
60 Degrees Pharmaceuticals, Inc. SXTP ██% $4M x 0.8x
Synlogic, Inc. SYBX ██% $8M x 0.6x
Spyre Therapeutics, Inc. SYRE ██% $5.72B x 8.5x
Syros Pharmaceuticals, Inc. SYRS ██% $20K -0.1x -0.4x
Takeda Pharmaceutical Co Ltd TAK ██% $51.09B x x
Theravance Biopharma, Inc. TBPH ██% $839M 7.3x 2.9x
Alaunos Therapeutics, Inc. TCRT ██% $7M x 5.5x
Telomir Pharmaceuticals, Inc. TELO ██% $87M x 17.6x
Tenax Therapeutics, Inc. TENX ██% $317M x 2.8x
Terns Pharmaceuticals, Inc. TERN ██% $6.12B x 6.1x
Teva Pharmaceutical Industries Ltd TEVA ██% $40.52B 25.9x 4.9x
Teva Pharmaceutical Industries Ltd TEVJF ██% $38.09B 53.4x 5.3x
Tg Therapeutics, Inc. TGTX ██% $5.97B 12.9x 10.2x
Canton Strategic Holdings, Inc. THAR ██% $186M x 30.2x
Talphera, Inc. TLPH ██% $41M x 2.2x
Telix Pharmaceuticals Ltd TLX ██% $3.22B x x
Tango Therapeutics, Inc. TNGX ██% $2.82B x 7.2x
Tonix Pharmaceuticals Holding Corp. TNXP ██% $202M x 0.9x
Theriva Biologics, Inc. TOVX ██% $14M x 0.9x
Tempest Therapeutics, Inc. TPST ██% $25M x 31.0x
Traws Pharma, Inc. TRAW ██% $17M -0.6x 1.5x
Entrada Therapeutics, Inc. TRDA ██% $258M x 1.0x
Trevi Therapeutics, Inc. TRVI ██% $1.82B x 10.6x
Trevena Inc TRVN ██% $260K -1.3x 1.5x
Turn Therapeutics Inc. TTRX ██% $156M x 25.5x
Tvardi Therapeutics, Inc. TVRD ██% $31M x 2.2x
Travere Therapeutics, Inc. TVTX ██% $4.39B x 44.5x
Therapeuticsmd, Inc. TXMD ██% $25M 139.7x 0.9x
Tyra Biosciences, Inc. TYRA ██% $1.96B x 5.1x
Unicycive Therapeutics, Inc. UNCY ██% $178M x 4.7x
Upstream Bio, Inc. UPB ██% $453M x 1.5x
Urogen Pharma Ltd. URGN ██% $1.44B x x
United Therapeutics Corp UTHR ██% $23.95B 18.6x 4.1x
Vaccinex, Inc. VCNX ██% $3M x x
Vera Therapeutics, Inc. VERA ██% $2.43B x 4.9x
Veru Inc. VERU ██% $39M -0.8x 2.1x
Sb Technology Holdings, Inc. VGLS ██% $710K x x
Sb Technology Holdings, Inc. VGLSD ██% $520K x x
Vicapsys Life Sciences, Inc. VICP ██% $47M x x
Vincerx Pharma, Inc. VINC ██% $70K -0.2x 0.0x
Viracta Therapeutics, Inc. VIRX ██% $390K -0.2x 0.2x
Viking Therapeutics, Inc. VKTX ██% $3.69B x 7.4x
Vanda Pharmaceuticals Inc. VNDA ██% $397M x 1.4x
Verrica Pharmaceuticals Inc. VRCA ██% $106M x 6.6x
Viridian Therapeutics, Inc.\De VRDN ██% $1.78B x 2.8x
Vireo Growth Inc. VREOF ██% $348M x 1.4x
Verona Pharma Plc VRNA ██% $73.55B -185.1x 264.3x
Virpax Pharmaceuticals, Inc. VRPX ██% $160K 0.0x -19.5x
Vertex Pharmaceuticals Inc / Ma VRTX ██% $112.99B 26.0x 5.8x
Verastem, Inc. VSTM ██% $372M x 4.6x
Vistagen Therapeutics, Inc. VTGN ██% $26M x 0.5x
Viatris Inc VTRS ██% $18.64B x 1.3x
Vtv Therapeutics Inc. VTVT ██% $0.00M -3.3x -7.5x
Ventyx Biosciences, Inc. VTYX ██% $999M -1.0x 5.2x
Vyne Therapeutics Inc. VYNE ██% $23M x 0.9x
Whitehawk Therapeutics, Inc. WHWK ██% $227M x 2.0x
Wave Life Sciences Ltd. WVE ██% $1.24B x 2.4x
Xenetic Biosciences, Inc. XBIO ██% $7M x 1.0x
Xbiotech Inc. XBIT ██% $74M x 0.6x
Exicure, Inc. XCUR ██% $18M x 4.5x
Xenon Pharmaceuticals Inc. XENE ██% $5.19B x 3.9x
Xeris Biopharma Holdings, Inc. XERS ██% $1.09B 90.7x 83.7x
Xilio Therapeutics, Inc. XLO ██% $49M x 0.7x
Xencor Inc XNCR ██% $870M x 1.7x
Xoma Royalty Corp XOMA ██% $496M 14.7x 5.3x
Xoma Royalty Corp XOMAO ██% $312M 14.4x 3.6x
Xoma Royalty Corp XOMAP ██% $326M 15.1x 3.7x
Xtl Biopharmaceuticals Ltd XTLB ██% $6M x x
Zenas Biopharma, Inc. ZBIO ██% $1.16B x 3.5x
Zai Lab Ltd ZLAB ██% $2.07B x 3.1x
Zentalis Pharmaceuticals, Inc. ZNTL ██% $284M x 1.6x
Zomedica Corp. ZOMDF ██% $132M x 1.1x
Zoetis Inc. ZTS ██% $33.31B 12.6x 10.3x
Zevra Therapeutics, Inc. ZVRA ██% $666M 5.4x 3.2x
Zyversa Therapeutics, Inc. ZVSA ██% $2M x x
Zymeworks Inc. ZYME ██% $1.75B -8.3x 6.5x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Prothena Corp Public Ltd Co Stock Forecast

How accurate are Prothena Corp Public Ltd Co stock predictions?

Our AI model shows a -5% Spearman correlation coefficient for PRTA predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Prothena Corp Public Ltd Co stock price forecasts?

Our analysis considers Prothena Corp Public Ltd Co's financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Prothena Corp Public Ltd Co a good investment in 2025?

Based on our AI analysis, Prothena Corp Public Ltd Co shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Prothena Corp Public Ltd Co forecasts updated?

Prothena Corp Public Ltd Co stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Prothena Corp Public Ltd Co?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...